CS-PDL1 Algorithm by NucleIQ® for

Lung Cancer

Automated PD-L1 Detection

Identifies and quantifies PD-L1 antibody–positive cells in lung tissue samples, which is crucial for guiding immunotherapy treatment in cancer.

Enhanced Standardization and Precision

It reduces interobserver variability and provides an accurate and standardized Tumor Proportion Score (TPS).

Streamlined diagnostic workflow

It accelerates the diagnostic process and therapeutic decision-making.

Comprehensive Slide Analysis

Examine the entire slide for a more complete and representative evaluation.

Support for Personalized Medicine

It facilitates the selection of patients for personalized immunotherapy treatments
Access to the website

The information on this website is intended exclusively for healthcare professionals; this content is not intended for the general public.